People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Prelude Corp | — | Biotechnology | Series A | $40.9M | $13.8M | 2019 |
| YAP Therapeutics Inc | — | Biotechnology | Series B | $30.1M | $618.3M | 2022 |
| Anaxiom Corp | — | Other Health Care | Series A | $9.5M | $19.7M | 2023 |
Andrew B. Wade at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew B. Wade on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Olav B. Bergheim | 3 | 13 |
| Hugh B. Neuharth | 2 | 7 |
| William J. Link | 1 | 10 |
| Gerrit B. Adams | 1 | 1 |
| Daniel B. Forche | 1 | 1 |
| Derek B. Maetzold | 1 | 1 |
| HUGH J. NEUHARTH | 1 | 1 |
| ANDREW J. WADE | 1 | 1 |
| DANIEL J. FORCHE | 1 | 1 |
| HAKON B. BERGHEIM | 1 | 1 |
| SHAHRAM B. MOADDEB | 1 | 1 |
| WILLIAM B. LINK | 1 | 1 |
| Alejandro B. Sanchez | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.